Dr. med. Klaus Rensing, MBA

Dr. Klaus Rensing spent many years in clinical medicine at the Universities in Heidelberg and Münster. In addition, he brings comprehensive business experience and expertise to the management team at Premier Healthcare Germany. Before joining the staff in October 2018, Dr. Klaus Rensing  built an impressive career through the development of medical strategies for university hospitals as well as leading private hospital chains in Germany and the United Arab Emirates. From 2011 to 2013, he served as Chief Medical Officer at Healthpoint Hospital in Abu Dhabi. His forward thinking and interests in advanced medical technologies as well as quality-driven clustered structures brought new structural and innovative methods, including advanced medicinal products, daVinci robotic systems and iORT devices, into the surgical practices there. His field research work at the German Cancer Research Center later became part of a Nobel Prize-winning study regarding human papillomavirus (HPV) vaccines to combat cervical cancer. Previously, as part of his numerous academic projects, Dr. Rensing gained considerable knowledge researching and working at Groote Schuur Hospital in Cape Town, SA, as well as in the US at Cornell University Medical Center and Memorial Sloan Kettering Cancer Center in New York. At Premier Healthcare Germany, Dr. Rensing is responsible for strategical and operational business development, medical advising and ensuring that company practices are in line with the most recent medical advancements and treatment options in the field.

Klaus speaks German and English